B cell‐dependent subtypes and treatment‐based immune correlates to survival in stage 3 and 4 lung adenocarcinomas.

Autor: Raju Paul, Susan^1,2,3 (AUTHOR), Valiev, Ivan⁴ (AUTHOR), Korek, Skylar E.^1,2 (AUTHOR), Zyrin, Vladimir⁴ (AUTHOR), Shamsutdinova, Diana⁴ (AUTHOR), Gancharova, Olga⁴ (AUTHOR), Zaitsev, Alexander⁴ (AUTHOR), Nuzhdina, Ekaterina⁴ (AUTHOR), Davies, Diane L.⁵ (AUTHOR), Dagogo‐Jack, Ibiayi^2,6 (AUTHOR), Frenkel, Felix⁴ (AUTHOR), Brown, Jessica H.⁴ (AUTHOR), Hess, Joshua M.¹ (AUTHOR), Viet, Sarah⁷ (AUTHOR), Petersen, Jason L.⁷ (AUTHOR), Wright, Cameron D.⁵ (AUTHOR), Ott, Harald C.⁵ (AUTHOR), Auchincloss, Hugh G.⁵ (AUTHOR), Muniappan, Ashok⁵ (AUTHOR), Shioda, Toshihiro^3,6 (AUTHOR)

Publikováno v: FASEB Bioadvances. Apr2023, Vol. 5 Issue 4, p156-170. 15p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cytometry profiling of ex vivo recall responses to Coxiella burnetii in previously naturally exposed individuals reveals long-term changes in both adaptive and innate immune cellular compartments.

Autor: Raju Paul S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Scholzen A; InnatOss Laboratories B.V., Oss, Netherlands., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Shepard R; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Hess JM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Dzeng RK; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Korek S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Garritsen A; InnatOss Laboratories B.V., Oss, Netherlands., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Oct 11; Vol. 14, pp. 1249581. Date of Electronic Publication: 2023 Oct 11 (Print Publication: 2023).

Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.

Autor: Scholzen A; InnatOss Laboratories B.V., Oss, Netherlands., Richard G; EpiVax, Inc., Providence, RI, United States., Moise L; EpiVax, Inc., Providence, RI, United States.; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States., Baeten LA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Reeves PM; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Martin WD; EpiVax, Inc., Providence, RI, United States., Brauns TA; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Boyle CM; EpiVax, Inc., Providence, RI, United States., Raju Paul S; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Bucala R; Department of Medicine, Yale University School of Medicine, New Haven, CT, United States., Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, United States., Garritsen A; InnatOss Laboratories B.V., Oss, Netherlands., De Groot AS; EpiVax, Inc., Providence, RI, United States.; Department of Cell and Molecular Biology, Institute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States., Sluder AE; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States., Poznansky MC; Vaccine and Immunotherapy Center, Massachusetts General Hospital, Boston, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2019 Feb 15; Vol. 10, pp. 207. Date of Electronic Publication: 2019 Feb 15 (Print Publication: 2019).